Yuyu Pharma Inc (000227) — Cash Flow Reinvestment Rate

Latest as of September 2025: 1.77x

Yuyu Pharma Inc (000227) has a Cash Flow Reinvestment Rate of 1.77x as of September 2025, reinvesting ₩1.48 Billion (capex ₩1.46 Billion plus investments ₩-22.80 Million) from operating cash flow of ₩836.62 Million. See Yuyu Pharma Inc (000227) free cash flow to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

1.77x
(Capex + Investments) / Operating CF

Total Reinvested

₩1.48 Billion
Capex + Investments

Operating Cash Flow

₩836.62 Million
KRW

Capital Expenditures

₩1.46 Billion
KRW

Yuyu Pharma Inc Cash Flow Reinvestment Rate (2014–2024)

Historical reinvestment intensity for Yuyu Pharma Inc across 8 annual periods. For the full cash flow conversion analysis, see Yuyu Pharma Inc (000227) cash conversion ratio.

Annual Cash Flow Reinvestment Rate for Yuyu Pharma Inc (2014–2024)

Year-by-year capital reinvestment analysis for Yuyu Pharma Inc. See Yuyu Pharma Inc (000227) financial flexibility to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (KRW) Operating CF Capex YoY Change
2024 0.37x ₩9.30 Billion ₩24.95 Billion ₩7.30 Billion ▼ -97.9%
2023 17.93x ₩7.55 Billion ₩420.86 Million ₩5.11 Billion ▲ +1205.4%
2021 1.37x ₩6.19 Billion ₩4.51 Billion ₩6.07 Billion ▲ +108.6%
2019 0.66x ₩8.68 Billion ₩13.19 Billion ₩8.06 Billion ▼ -59.2%
2018 1.61x ₩9.87 Billion ₩6.11 Billion ₩9.76 Billion ▼ -83.4%
2017 9.74x ₩5.46 Billion ₩561.35 Million ₩5.19 Billion ▲ +2433.5%
2016 0.38x ₩3.77 Billion ₩9.82 Billion ₩2.32 Billion ▼ -80.8%
2014 2.00x ₩2.73 Billion ₩1.36 Billion ₩404.37 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow